Medicines planning
49 results
Applied filters
Costing clinical trials of ATIMPs using the NIHR iCT
11 February 2026Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
Exagamglogene autotemcel (Casgevy®)
13 February 2026This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of exagamglogene autotemcel.
National Homecare Medicines Committee (NHMC) Homecare Digital Strategy
4 August 2020This is the NHMC and NCHA joint digital strategy and roadmap for the next 5 years. It sets out a direction of travel for homecare…
National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice
4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…
National Homecare Medicines Committee (NHMC) Homecare Service Proposal (HSP) Form
25 November 2021The Homecare Service Proposal (HSP) Form is to be completed by pharmaceutical manufacturers where there are new homecare medicines services or where there are changes…
National Homecare Medicines Committee regional contacts
12 May 2025Contact details of the homecare regional specialists within the UK who sit on the National Homecare Medicines Committee (NHMC).
National Homecare Medicines Committee (NHMC) Terms of Reference
5 April 2018National Homecare Medicines Committee (NHMC) The NHMC is a sub group of the National Pharmaceutical Market Supply Group (NPSG) and acts as the national focus…
The licence and supporting evidence for ranibizumab biosimilars
5 November 2025Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
Understanding patents
11 July 2025Patents allow the inventor a finite period of monopoly in exchange for publicising the idea. We explain how they work with respect to medicines.
Preparing to use denosumab 60mg biosimilar
16 January 2026Biosimilars of denosumab 60mg (Prolia) are available. We offer general information and implementation advice.